MedAcuity and Haply Robotics have entered into a strategic partnership to drive forward innovation in precision haptics for medical and robotic technologies. By combining Haply's pioneering haptic interface solutions with MedAcuity's expertise in regulatory-grade software development, the collaboration will focus on creating next-generation teleoperation systems designed for surgical, diagnostic, and simulation use. The partnership aims to deliver real-time, high-accuracy tactile feedback systems that enhance control, safety, and performance across remote medical and robotic applications.
MedAcuity, a leading software engineering company specialising in complex medical and robotic systems, has announced a strategic partnership with Montréal-based Haply Robotics, a global innovator in haptic and robotic interface technologies. Together, the two firms will accelerate the development of advanced teleoperated systems that unite precision engineering with state-of-the-art haptic feedback, transforming the landscape of remote healthcare, simulation, and training experiences.
The partnership integrates Haply's industry-leading technologies--including the award-winning Inverse3X and MinVerse devices--with MedAcuity's depth of knowledge in software architecture, systems integration, and regulatory-compliant development. By fusing cutting-edge tactile technologies with robust, safety-critical software, the collaboration will deliver systems designed to optimise operator control, fidelity, and reliability in high-stakes scenarios.
"This collaboration represents a natural alignment of strengths," said Dennis Fuccione, President of MedAcuity. "Haply Robotics is at the forefront of human machine interaction, and together, we are poised to push the boundaries of what's possible in remote robotic control and medical device innovation."
"Partnering with MedAcuity allows us to bring our advanced haptic technologies into new domains where precision and reliability are critical," said Colin Gallacher, President of Haply Robotics. "Their proven track record in regulated medical and robotic systems complements our mission to deliver intuitive, tactile experiences that elevate human control in remote environments. Together, we're enabling a new standard for human machine interaction."
Under this collaboration, the companies will jointly develop a portfolio of applications encompassing robotic-assisted surgery, remote diagnostics, and immersive simulation training. Each solution will be built with an emphasis on providing real-time, high-fidelity tactile feedback to enhance user precision, responsiveness, and confidence.
As industries increasingly demand more intuitive and responsive human–robot interfaces--particularly within telemedicine, defence, and industrial automation--the MedAcuity–Haply partnership is well-positioned to lead the next phase of innovation in haptic and teleoperated technologies.
source:newsreleases.co.uk
Aetna to launch generative AI-powered conversational experience
Maxx Orthopedics Receives FDA 510(k) Clearance for Its Libertas® Bipolar Hip System
Ascletis Pharma announces ASC36 and ASC35 co-formulation for clinical development
Adocia files patent for long-acting peptide platform AdoXLong and updates on BioChaperone studies
Nurami Medical completes Phase 1 milestones in EIC-backed grant for Artifix
Organon to sell JADA System to Laborie for up to USD465m
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
BD launches IVDR-certified self-collection solution to expand global access to HPV testing
Oticon launches Oticon Zeal, a discreet, fully featured in-the-ear hearing aid
Halozyme Therapeutics announces Q3 2025 release date
Samsung to invest USD110m in GRAIL and commercialise cancer detection test Galleri in Asia
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025